» Articles » PMID: 8091657

Control of Expression, Glycosylation, and Secretion of HIV-1 Gp120 by Homologous and Heterologous Signal Sequences

Overview
Journal Virology
Specialty Microbiology
Date 1994 Oct 1
PMID 8091657
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

The HIV-1 gp120 signal sequence of 30 amino acids is longer than most glycoprotein signal sequences and contains an average of 5 positively charged amino acids. The HIV-1 gp120 gene with its natural signal sequence expressed in any prokaryotic or eukaryotic expression systems showed extremely low levels of synthesis and secretion. However, deletion of the HIV-1 gp120 signal sequence results in production of large quantities of a nonglycosylated form of gp120 in Spodoptera frugiperda cells. Substitution of the gp120 natural signal sequences with the signal sequences from honeybee mellitin or murine interleukin 3 promotes a high level of expression of a glycosylated form of gp120 and efficient secretion. These heterologous signal sequences contain one (mellitin) or no (IL-3) positively charged amino acids and led us to investigate the role of the positively charged amino acids in the signal sequence of HIV-1 gp120. Four charge-altered forms of the gp120 signal sequence of HIV-1 were constructed by site-directed mutagenesis in which the positively charged amino acids were sequentially substituted with neutral amino acids. The results of these experiments showed that the expression and secretion of gp120 was progressively increased by eliminating the positively charged amino acids in a stepwise fashion. However, the substitution of all positively charged amino acids resulted in the accumulation of nonglycosylated gp120 within the cells with decreased amounts of the glycosylated form of gp120. These results demonstrate that the positively charged amino acids in the signal sequence of HIV-1 gp120 are key factors in determining its poor expression and secretion. Analyses of intracellular transport and folding of gp120 further indicate that the presence of a highly charged, uncleaved signal sequence is an important factor limiting transport of gp120 from the rough ER to the Golgi apparatus.

Citing Articles

Signal peptide exchange alters HIV-1 envelope antigenicity and immunogenicity.

Upadhyay C, Rao P, Behzadi M, Feyznezhad R, Lambert G, Kumar R Front Immunol. 2024; 15():1476924.

PMID: 39380992 PMC: 11458420. DOI: 10.3389/fimmu.2024.1476924.


Optimal Expression, Function, and Immunogenicity of an HIV-1 Vaccine Derived from the Approved Ebola Vaccine, rVSV-ZEBOV.

Azizi H, Knapp J, Li Y, Berger A, Lafrance M, Pedersen J Vaccines (Basel). 2023; 11(5).

PMID: 37243081 PMC: 10223473. DOI: 10.3390/vaccines11050977.


Optimizing the Production of gp145, an HIV-1 Envelope Glycoprotein Vaccine Candidate and Its Encapsulation in Guanosine Microparticles.

Akamine P, Gonzalez-Feliciano J, Almodovar R, Morell G, Rivera J, Capo-Velez C Vaccines (Basel). 2023; 11(5).

PMID: 37243079 PMC: 10221277. DOI: 10.3390/vaccines11050975.


Epidemiological surveillance of Newcastle disease virus in Egypt - a 6-year cohort study.

Abozaid K, Abdel-Moneim A Trop Anim Health Prod. 2022; 54(4):243.

PMID: 35909216 DOI: 10.1007/s11250-022-03234-3.


A vesicular stomatitis virus-based prime-boost vaccination strategy induces potent and protective neutralizing antibodies against SARS-CoV-2.

Kim G, Choi J, Wu K, Saeedian N, Yang E, Park H PLoS Pathog. 2021; 17(12):e1010092.

PMID: 34914812 PMC: 8675757. DOI: 10.1371/journal.ppat.1010092.